Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study.
Zheng SL, Liu W, Wiklund F, Dimitrov L, Bälter K, Sun J, Adami HO, Johansson JE, Sun J, Chang B, Loza M, Turner AR, Bleecker ER, Meyers DA, Carpten JD, Duggan D, Isaacs WB, Xu J, Grönberg H. Zheng SL, et al. Among authors: balter k. Prostate. 2006 Oct 1;66(14):1556-64. doi: 10.1002/pros.20496. Prostate. 2006. PMID: 16921508
Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
Sun J, Wiklund F, Hsu FC, Bälter K, Zheng SL, Johansson JE, Chang B, Liu W, Li T, Turner AR, Li L, Li G, Adami HO, Isaacs WB, Xu J, Grönberg H. Sun J, et al. Among authors: balter k. Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):480-5. doi: 10.1158/1055-9965.EPI-05-0645. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16537705
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.
Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, Wiklund F, Robbins C, Isaacs SD, Cheng Y, Li G, Sun J, Chang BL, Marovich L, Wiley KE, Bälter K, Stattin P, Adami HO, Gielzak M, Yan G, Sauvageot J, Liu W, Kim JW, Bleecker ER, Meyers DA, Trock BJ, Partin AW, Walsh PC, Isaacs WB, Grönberg H, Xu J, Carpten JD. Duggan D, et al. Among authors: balter k. J Natl Cancer Inst. 2007 Dec 19;99(24):1836-44. doi: 10.1093/jnci/djm250. Epub 2007 Dec 11. J Natl Cancer Inst. 2007. PMID: 18073375
Cumulative association of five genetic variants with prostate cancer.
Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Bälter K, Kader AK, Turner AR, Liu W, Bleecker ER, Meyers DA, Duggan D, Carpten JD, Chang BL, Isaacs WB, Xu J, Grönberg H. Zheng SL, et al. Among authors: balter k. N Engl J Med. 2008 Feb 28;358(9):910-9. doi: 10.1056/NEJMoa075819. Epub 2008 Jan 16. N Engl J Med. 2008. PMID: 18199855 Free article.
A multigenic approach to evaluating prostate cancer risk in a systematic replication study.
Hsu FC, Lindström S, Sun J, Wiklund F, Chen SH, Adami HO, Turner AR, Liu W, Bälter K, Kim JW, Stattin P, Chang BL, Isaacs WB, Xu J, Grönberg H, Zheng SL. Hsu FC, et al. Among authors: balter k. Cancer Genet Cytogenet. 2008 Jun;183(2):94-8. doi: 10.1016/j.cancergencyto.2008.02.008. Cancer Genet Cytogenet. 2008. PMID: 18503826 Free PMC article.
Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk.
Lindmark F, Zheng SL, Wiklund F, Bälter KA, Sun J, Chang B, Hedelin M, Clark J, Johansson JE, Meyers DA, Adami HO, Isaacs W, Grönberg H, Xu J. Lindmark F, et al. Among authors: balter ka. Br J Cancer. 2005 Aug 22;93(4):493-7. doi: 10.1038/sj.bjc.6602729. Br J Cancer. 2005. PMID: 16106254 Free PMC article.
96 results